An olfactory 'stress test' may detect preclinical Alzheimer's disease

44Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The olfactory bulb (OB) receives extensive cholinergic input from the basal forebrain and is affected very early in Alzheimer's disease (AD). We speculated that an olfactory 'stress test' (OST), targeting the OB, might be used to unmask incipient AD. We investigated if change in olfactory performance following intranasal atropine was associated with several known antecedents or biomarkers of AD.Methods: We measured change in performance on the University of Pennsylvania Smell Identification Test (UPSIT) in the left nostril before (20-items) and after (remaining 20-items) intranasal administration of 1 mg of atropine. We administered cognitive tests, measured hippocampal volume from MRI scans and recorded Apolipoprotein E genotype as indices relevant to underlying AD.Results: In a convenience sample of 56 elderly individuals (14 probable AD, 13 cognitive impairment no dementia, 29 cognitively intact) the change in UPSIT score after atropine ('atropine effect' = AE) correlated significantly with demographically scaled episodic memory score (r = 0.57, p < 0.001) and left hippocampal volume (LHCV) (r = 0.53, p < 0.001). Among non-demented individuals (n = 42), AE correlated with episodic memory (r = 0.52, p < 0.001) and LHCV (r = 0.49, p < 0.001) and hierarchical linear regression models adjusted for age, gender, education, and baseline UPSIT showed that the AE explained more variance in memory performance (24%) than did LHCV (15%). The presence of any APOE ε{lunate}4 allele was associated with a more negative AE (p = 0.014).Conclusions: The OST using atropine as an olfactory probe holds promise as a simple, inexpensive screen for early and preclinical AD and further work, including longitudinal studies, is needed to explore this possibility. © 2012 Schofield et al.; licensee BioMed Central Ltd.

References Powered by Scopus

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician

77989Citations
N/AReaders
Get full text

Clinical diagnosis of alzheimer’s disease: Report of the NINCDS-ADRDA work group⋆ under the auspices of department of health and human services task force on alzheimer’s disease

26512Citations
N/AReaders
Get full text

Neuropathological stageing of Alzheimer-related changes

13125Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Olfactory and other sensory impairments in Alzheimer disease

288Citations
N/AReaders
Get full text

Olfactory bulb involvement in neurodegenerative diseases

251Citations
N/AReaders
Get full text

Innovative diagnostic tools for early detection of Alzheimer's disease

237Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Schofield, P. W., Ebrahimi, H., Jones, A. L., Bateman, G. A., & Murray, S. R. (2012). An olfactory “stress test” may detect preclinical Alzheimer’s disease. BMC Neurology, 12. https://doi.org/10.1186/1471-2377-12-24

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 47

58%

Researcher 21

26%

Professor / Associate Prof. 12

15%

Lecturer / Post doc 1

1%

Readers' Discipline

Tooltip

Medicine and Dentistry 29

41%

Psychology 16

23%

Agricultural and Biological Sciences 15

21%

Neuroscience 11

15%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free